Defendant Name: Wasatch Pharmaceutical, Inc.

Defendant Type: Other

Initial Case Details

Legal Case Name SEC v. Frank J. Custable, Jr., Sara Wetzel, Suburban Capital Corporation, Francis Scott Widen, Wasatch Pharmaceutical Inc., David Giles, Gary Heesch, Pacel Corporation, David Calkins, Gateway Distributors, Ltd., Richard Bailey, and Thermoelastic Technologies, Inc.
First Document Date 01-Apr-2003
Initial Filing Format Civil Proceeding
Case Number 03-cv-02182
Allegation Type Issuer Reporting and Disclosure
Federal District Court Illinois, Northern District of Illinois

Violations Alleged

Exchange Act
Sec 10(b) + Rule 10b-5
Securities Act
Sec 5
Sec 5(a)
Sec 5(c)
Sec 17(a)(1)
Sec 17(a)(2)
Sec 17(a)(3)
Sec 17(a) (Not specified)

Resolutions

First Resolution Date 23-Feb-2010

Related Documents:

comp18057 01-Apr-2003 Complaint
Complaint for Injunctive and Other Equitable Relief
According to the SEC: "This case concerns an ongoing scheme to violate the registration, antifraud and reporting provisions of the federal securities laws. Defendant Frank J. Custable, Jr. ("Custable"), a recidivist securities law violator, has orchestrated the multi-faceted scheme from its inception in 2001 until the present. Custable's scheme has involved the securities of at least seven small public companies and has generated more than $4 million in ill-gotten gains."
LR-21423 23-Feb-2010 Litigation Release
SEC Obtains Final Judgments Against 12 Defendants in Penny Stock Scheme
On February 23, 2010, the SEC published a litigation release announcing that Wasatch Pharmaceutical, Inc. entered a final judgment, by consent, in this matter.

Other Defendants in Action: